Cargando…
A1 TARGETING IL-4 AND IL-13 TO TREAT CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS IN SHIP DEFICIENT MICE
BACKGROUND: Crohn’s disease (CD) is an immune-mediated disease characterized by chronic, relapsing and remitting, or progressive inflammation of the digestive tract. One in 3 people with CD will develop intestinal fibrosis requiring surgery within 10 years of diagnosis. Biological therapy is effecti...
Autores principales: | Safari, K, Menzies, S, Jung, H, Sly, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991372/ http://dx.doi.org/10.1093/jcag/gwac036.001 |
Ejemplares similares
-
IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity
por: Rauch, Daniel A, et al.
Publicado: (2014) -
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015) -
Sputum “IL-5, IL-17A, IL-25-high” pattern is associated with uncontrolled asthma and worse lung function
por: Seys, Sven, et al.
Publicado: (2013) -
Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice
por: Dobranowski, Peter Allan, et al.
Publicado: (2019) -
Effect of the combination of the proinflammatory cytokines IL-1, tumor necrosis factor-α and IL-17
por: Miossec, P, et al.
Publicado: (2003)